Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Liabilities (2020 - 2025)

Journey Medical (DERM) has disclosed Total Liabilities for 6 consecutive years, with $59.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Liabilities rose 11.63% year-over-year to $59.3 million, compared with a TTM value of $59.3 million through Sep 2025, up 11.63%, and an annual FY2024 reading of $60.2 million, up 6.5% over the prior year.
  • Total Liabilities was $59.3 million for Q3 2025 at Journey Medical, down from $61.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $100.8 million in Q3 2021 and bottomed at -$10.8 million in Q1 2021.
  • Average Total Liabilities over 5 years is $60.2 million, with a median of $60.2 million recorded in 2024.
  • The sharpest move saw Total Liabilities surged 9836.99% in 2022, then crashed 40.77% in 2023.
  • Year by year, Total Liabilities stood at $55.2 million in 2021, then surged by 59.62% to $88.2 million in 2022, then crashed by 35.93% to $56.5 million in 2023, then increased by 6.5% to $60.2 million in 2024, then fell by 1.46% to $59.3 million in 2025.
  • Business Quant data shows Total Liabilities for DERM at $59.3 million in Q3 2025, $61.9 million in Q2 2025, and $63.4 million in Q1 2025.